Replimune aims to raise $125M; Ot­su­ka makes an­oth­er deal with Io­n­is

Plus, news about Kan­glin Biotech­nol­o­gy, See­los, Or­bus and Sonata:

Replimune’s $125M of­fer­ing: The biotech an­nounced the of­fer­ing four days af­ter it …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.